InVitro International
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVRO research report →
About the company
Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness.
- CEO
- W. Richard Ulmer
- IPO
- 1991
- Employees
- 6
- HQ
- Placentia, CA, US
Price Chart
- Market Cap
- $1.90M
- P/E
- 18.96
- P/S
- 2.29
- P/B
- 1.12
- EV/EBITDA
- 9.59
- Div Yield
- 0.00%
- Gross Margin
- 81.83%
- Op Margin
- 8.60%
- Net Margin
- 12.19%
- ROE
- 6.05%
- ROIC
- 3.57%
- Revenue
- $878.94K · 8.34%
- Net Income
- $121.98K · 14.32%
- EPS
- $0.01 · 14.89%
- Op Income
- $87.02K
- FCF YoY
- -108.80%
- 52W High
- $0.16
- 52W Low
- $0.03
- 50D MA
- $0.08
- 200D MA
- $0.09
- Beta
- -0.80
- Avg Volume
- 17.34K
Get TickerSpark's AI analysis on IVRO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IVRO coverage
Recent articles, reports, and earnings notes.
No research on IVRO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVRO report →Similar companies
Peers in the same neighborhood.